Similar Search Results

Copyright and Trademark Issues in the Pharmaceutical Industry : Generic Compliance or Brand Drug Imitating: 'Copycat or Compliance'

Termini, Roseann B.; Miele, Amy - 2014

Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation...

Persistent link: https://www.econbiz.de/10014161252

Blockchain for Combating Pharmaceutical Drug Counterfeiting and Cold Chain Distribution

Sarkar, Shambhu - 2023

digital supply chain's transparency and visibility. Blockchain-based drug traceability proposes a promising solution to create … provides a thorough analysis and summary of the current state of drug traceability distribution research on the blockchain … platform by using Hyperledger febric and Hyperledger Besu methodologies. Blockchain based platform, Hyperledger Fabric and Besu …

Persistent link: https://www.econbiz.de/10014345734

Exploring relationship between brand equity and customer loyalty on pharmaceutical market

Dlačić, Jasmina; Kežman, Elvedina - In: Economic and business review : EBR 16 (2014) 2, pp. 121-131

Persistent link: https://www.econbiz.de/10011612102

Should product-specific advertisement be regulated in pharmaceutical markets?

Ishida, Junichiro; Takahara, Tsuyoshi - 2022

This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends crucially on the cost effectiveness of...

Persistent link: https://www.econbiz.de/10013329470

Pharmaceutical regulation in Europe and its impact on corporate R&D

Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9

Objectives: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...

Persistent link: https://www.econbiz.de/10010526909

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Challenges of the COVID-19 pandemic to pharmaceutical manufacturing : the EU and Ukraine's response

Salikhova, Olena; Honcharenko, Daria - In: Economy and forecasting : scientific journal (2021) 3, pp. 88-113

Persistent link: https://www.econbiz.de/10013163669

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

Optimal patent policy for pharmaceutical industry

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020

Persistent link: https://www.econbiz.de/10012439514

1
2
3
4
5
6
7
8
9
10
Next
Last